Medpace Holdings (MEDP) Depreciation & Amortization (CF) (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Depreciation & Amortization (CF) data on file, last reported at $6.6 million in Q2 2026.

• Quarterly Depreciation & Amortization (CF) fell 3.28% year-over-year to $6.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $27.0 million (down 2.66% YoY) and the FY2025 annual result came in at $27.2 million, down 2.19% from the prior year.
• Depreciation & Amortization (CF) fell to $6.6 million in Q2 2026, from $6.8 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $7.2 million in Q3 2024 to a low of $4.3 million in Q1 2022.
• A 5-year average of $6.2 million and a median of $6.6 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) advanced 27.83% — and 2025, when it dropped 4.82%.
• Tracing MEDP's Depreciation & Amortization (CF) over 5 years: stood at $5.1 million in 2022, then rose by 26.62% to $6.4 million in 2023, then rose by 11.26% to $7.1 million in 2024, then dropped by 3.21% to $6.9 million in 2025, then retreated by 5.22% to $6.6 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $6.6 million (Q2 2026), $6.8 million (Q1 2026), and $6.9 million (Q4 2025), per Business Quant data.